[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3105 Introduced in Senate (IS)]
<DOC>
119th CONGRESS
1st Session
S. 3105
To regulate human cadaveric islets for transplantation as organs.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
November 5, 2025
Mr. Lee (for himself and Mr. Budd) introduced the following bill; which
was read twice and referred to the Committee on Health, Education,
Labor, and Pensions
_______________________________________________________________________
A BILL
To regulate human cadaveric islets for transplantation as organs.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Increase Support for Life-saving
Endocrine Transplantation Act'' or the ``ISLET Act''.
SEC. 2. REGULATION OF HUMAN CADAVERIC ISLET TRANSPLANTS.
(a) In General.--Section 374(d)(2) of the Public Health Service Act
(42 U.S.C. 274b(d)(2)) is amended by striking ``pancreas,'' and
inserting ``and pancreas, human cadaveric islets,''.
(b) Clarification.--Notwithstanding any other provision of law,
none of the following terms includes human cadaveric islets:
(1) The term ``drug'', as defined in section 201(g) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)).
(2) The term ``biological product'', as defined in section
351(i) of the Public Health Service Act (42 U.S.C. 262(i)).
(3) The term ``human cells, tissues, or cellular or tissue-
based products (HCT/Ps)'', as defined in section 1271.3 of
title 21, Code of Federal Regulations (or any successor
regulations).
(c) Regulations.--
(1) In general.--Not later than 1 year after the date of
enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the ``Secretary'')
shall update regulations promulgated under parts F, G, and H of
title III of the Public Health Service Act (42 U.S.C. 262 et
seq., 264 et seq., 273 et seq.) and the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 301 et seq.), and such other
regulations as the Secretary determines appropriate, to carry
out the amendment made by subsection (a).
(2) Report.--Not later than 6 months after the date of
enactment of this Act, the Secretary shall report to Congress
on the progress made in updating regulations as required under
paragraph (1).
<all>